{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:09:30Z","timestamp":1772431770804,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), recently redefined from non-alcoholic fatty liver disease, commonly coexists with type 2 diabetes mellitus and may adversely affect skeletal health through inflammation and insulin resistance. However, research on site-specific bone mineral density (BMD) effects in South Asian populations, particularly Indians, remains limited. This study aimed to evaluate the association between MASLD and BMD at different skeletal sites among adults with type 2 diabetes mellitus in North India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included 100 adults (50 with T2DM and 50 controls) at a tertiary care center in Jaipur, India. MASLD was evaluated using the fibrosis-4 (FIB-4) index, hepato-renal index, and two-dimensional shear wave elastography. BMD at lumbar spine (L1-L4), left total hip (proximal femur), and left forearm was assessed by dual-energy X-ray absorptiometry. Associations between MASLD parameters and BMD were analyzed using multivariable linear regression, adjusting for age, sex, and smoking status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      T2DM patients showed significantly lower lumbar spine (L1-L4) BMD (0.93 vs. 0.98 g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      ; P = 0.026) and T-scores (-1.33 vs. -0.72; P = 0.004), especially in males \u226550 years. No statistically significant differences were observed in proximal femur and forearm BMD between groups. FIB-4 scores were higher (P = 0.004), with 60% at intermediate-to-high fibrosis risk versus 28% of controls; advanced fibrosis occurred in 10% vs. 2%. Hepatic steatosis positively associated with hip BMD (\u03b2=0.738; P = 0.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study establishes significant, site-specific associations between MASLD and reduced bone mineral density in type 2 diabetes mellitus patients, particularly affecting trabecular-rich skeletal sites. The complex relationship between hepatic steatosis and skeletal health highlights the multisystemic nature of metabolic dysfunction. These findings support integrating bone health assessments and non-invasive hepatic fibrosis screening into routine diabetes care to improve early risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1758966","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:21:03Z","timestamp":1772428863000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction-associated steatotic liver disease and bone mineral density in type 2 diabetes mellitus: insights from a single-center cross-sectional study in North India"],"prefix":"10.3389","volume":"17","author":[{"given":"Dogga","family":"Sudhakar","sequence":"first","affiliation":[{"name":"Department of Endocrinology, National Institute of Medical Sciences and Research Hospital, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Rajotiya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nims Institute of Pharmacy, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourav","family":"Debnath","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nims Institute of Pharmacy, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, National Institute of Medical Sciences and Research Hospital, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monal","family":"Sherekar","sequence":"additional","affiliation":[{"name":"Family Medicine Consultant, Connect and Heal Primary Care Pvt Ltd.","place":["Bengaluru, Karnatak, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivang","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nims Institute of Pharmacy, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nims Institute of Pharmacy, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahaveer","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, National Institute of Medical Sciences and Research Hospital, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Munshi","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Institute of Medical Sciences and Research Hospital, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nims Institute of Pharmacy, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balvir Singh","family":"Tomar","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Hepatology & Transplant, Nims University Rajasthan","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Elhence","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13300-025-01748-1","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease: mapping across different Indian populations (MAP study)","volume":"17","author":"Mohan","year":"2025","journal-title":"Diabetes Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14218\/JCTH.2019.00051","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations","volume":"8","author":"Kumar","year":"2019","journal-title":"J Clin Trans Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07217-y","article-title":"Metabolic dysfunction\u2013associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity","volume":"35","author":"Tao","year":"2024","journal-title":"Osteoporosis Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06459-y","article-title":"Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"33","author":"Pan","year":"2022","journal-title":"Osteoporosis Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15087","article-title":"Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density","volume":"49","author":"Mantovani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0807-2","article-title":"Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis","volume":"35","author":"Upala","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1156996","article-title":"Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study","volume":"14","author":"Chung","year":"2023","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101437","DOI":"10.1016\/j.jocd.2023.101437","article-title":"DXA reporting updates: 2023 official positions of the International Society for Clinical Densitometry","volume":"27","author":"Krueger","year":"2024","journal-title":"J Clin Densitometry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-024-00867-1","article-title":"Diagnosing osteoporosis in diabetes \u2014 A systematic review on BMD and fractures","volume":"22","author":"Brandt","year":"2024","journal-title":"Curr Osteoporos Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.22382","article-title":"Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis","volume":"44","author":"Chauhan","year":"2016","journal-title":"J Clin Ultrasound"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30204-3","article-title":"Epidemiology and determinants of type 2 diabetes in south Asia","volume":"6","author":"Hills","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13534","article-title":"Deciphering the \u201cobesity paradox\u201d in the elderly: A systematic review and meta-analysis of sarcopenic obesity","volume":"24","author":"Liu","year":"2023","journal-title":"Obes Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)02982-0","article-title":"Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease","volume":"41","author":"Reaven","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4103\/1735-1995.168383","article-title":"Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components","volume":"20","author":"Zadhoush","year":"2015","journal-title":"J Res Med Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/life14020272","article-title":"NAFLD fibrosis progression and type 2 diabetes: the hepatic\u2013metabolic interplay","volume":"14","author":"Cernea","year":"2024","journal-title":"Life"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.21037\/qims-21-895","article-title":"Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease","volume":"12","author":"Kim","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2522014","DOI":"10.1155\/2022\/2522014","article-title":"Diabetes mellitus is associated with poor bone microarchitecture in long-term care residents","volume":"2022","author":"Haeri","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13300-020-00964-1","article-title":"Diabetes and bone fragility","volume":"12","author":"Romero-D\u00edaz","year":"2021","journal-title":"Diabetes Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/medicina61050789","article-title":"Type 2 diabetes mellitus and osteoporosis: site-specific bone mineral density variations and metabolic correlations in postmenopausal saudi women","volume":"61","author":"Alhowiti","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03926-w","article-title":"The paradox of bone mineral density and fracture risk in type 2 diabetes","volume":"85","author":"Li","year":"2024","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1278505","article-title":"Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia\/osteoporosis in T2DM patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.7570\/jomes24004","article-title":"Effects of metabolic dysfunction-associated steatotic liver disease on bone density and fragility fractures: associations and mechanisms","volume":"33","author":"Khanmohammadi","year":"2024","journal-title":"J Obes Metab Syndr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i5.825","article-title":"Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health","volume":"29","author":"Jadzic","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02130-3","article-title":"Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses","volume":"47","author":"Jadzic","year":"2024","journal-title":"J Endocrinol Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1758966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:21:04Z","timestamp":1772428864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1758966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1758966"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1758966","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"1758966"}}